Common Stock, Shares, Issued of NEUROCRINE BIOSCIENCES INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NEUROCRINE BIOSCIENCES INC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 100,100,000, a 0.7% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 100,100,000 +700,000 +0.7% 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q3 2025 99,700,000 -1,500,000 -1.5% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 99,000,000 -1,900,000 -1.9% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 99,000,000 -1,600,000 -1.6% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 99,400,000 +700,000 +0.71% 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q3 2024 101,200,000 +3,000,000 +3.1% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 100,900,000 +3,300,000 +3.4% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 100,600,000 +3,100,000 +3.2% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 98,700,000 +2,200,000 +2.3% 31 Dec 2023 10-K 10 Feb 2025 2024 FY
Q3 2023 98,200,000 +2,100,000 +2.2% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 97,600,000 +2,000,000 +2.1% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 97,500,000 +2,000,000 +2.1% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 96,500,000 +1,600,000 +1.7% 31 Dec 2022 10-K 09 Feb 2024 2023 FY
Q3 2022 96,100,000 +1,300,000 +1.4% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 95,600,000 +1,000,000 +1.1% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 95,500,000 +1,000,000 +1.1% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 94,900,000 +1,400,000 +1.5% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q3 2021 94,800,000 +1,400,000 +1.5% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 94,600,000 +1,400,000 +1.5% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 94,500,000 +1,700,000 +1.8% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 93,500,000 +1,200,000 +1.3% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 93,400,000 +1,320,000 +1.4% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 93,200,000 +1,664,000 +1.8% 30 Jun 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 92,800,000 +1,516,000 +1.7% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 92,300,000 +1,503,000 +1.7% 31 Dec 2019 10-K 05 Feb 2021 2020 FY
Q3 2019 92,080,000 +1,406,786 +1.6% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 91,536,000 +1,132,762 +1.3% 30 Jun 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 91,284,000 +1,401,938 +1.6% 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 90,797,000 +2,003,097 +2.3% 31 Dec 2018 10-K 07 Feb 2020 2019 FY
Q3 2018 90,673,214 +2,211,212 +2.5% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 90,403,238 +2,186,370 +2.5% 30 Jun 2018 10-Q 31 Jul 2018 2018 Q2
Q1 2018 89,882,062 +2,362,152 +2.7% 31 Mar 2018 10-Q 30 Apr 2018 2018 Q1
Q4 2017 88,793,903 +1,910,603 +2.2% 31 Dec 2017 10-K 08 Feb 2019 2018 FY
Q3 2017 88,462,002 +1,595,889 +1.8% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 88,216,868 +1,465,235 +1.7% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 87,519,910 +946,834 +1.1% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 86,883,300 +620,706 +0.72% 31 Dec 2016 10-K 13 Feb 2018 2017 FY
Q3 2016 86,866,113 +981,985 +1.1% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 86,751,633 +1,001,262 +1.2% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 86,573,076 +1,200,773 +1.4% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 86,262,594 +9,796,652 +13% 31 Dec 2015 10-K 14 Feb 2017 2016 FY
Q3 2015 85,884,128 +9,887,744 +13% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 85,750,371 +9,831,362 +13% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 85,372,303 +9,513,622 +13% 31 Mar 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 76,465,942 +9,114,747 +14% 31 Dec 2014 10-K 11 Feb 2016 2015 FY
Q3 2014 75,996,384 +8,653,177 +13% 30 Sep 2014 10-Q 04 Nov 2014 2014 Q3
Q2 2014 75,919,009 +8,920,906 +13% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 75,858,681 +9,146,307 +14% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 67,351,195 +904,307 +1.4% 31 Dec 2013 10-K 09 Feb 2015 2014 FY
Q3 2013 67,343,207 +962,072 +1.4% 30 Sep 2013 10-Q 29 Oct 2013 2013 Q3
Q2 2013 66,998,103 +677,878 +1% 30 Jun 2013 10-Q 26 Jul 2013 2013 Q2
Q1 2013 66,712,374 +406,072 +0.61% 31 Mar 2013 10-Q 02 May 2013 2013 Q1
Q4 2012 66,446,888 +11,184,154 +20% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 66,381,135 +11,127,119 +20% 30 Sep 2012 10-Q 31 Oct 2012 2012 Q3
Q2 2012 66,320,225 +11,083,329 +20% 30 Jun 2012 10-Q 31 Jul 2012 2012 Q2
Q1 2012 66,306,302 31 Mar 2012 10-Q 02 May 2012 2012 Q1
Q4 2011 55,262,734 +380,605 +0.69% 31 Dec 2011 10-K 08 Feb 2013 2012 FY
Q3 2011 55,254,016 30 Sep 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 55,236,896 30 Jun 2011 10-Q 29 Jul 2011 2011 Q2
Q4 2010 54,882,129 31 Dec 2010 10-K 09 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.